×

Health

Company wins approval for lymphoma drug

NEW YORK (AP) - U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma. The Food and Drug Administration granted accelerated approval to AstraZeneca PLC’s Calquence for people with mantle cell lymphoma after chemotherapy or other treatments fail. ...

Move over, dodgeball: Schools pump up physical education with choices

By Carolyn Thompson Associated Press You won’t find gym class on the schedule in upstate New York’s Victor school district. What you will see: kayaking, rock climbing, mountain biking, dance, self-defense, archery and in-line skating — all under the heading of physical education. The ...

Baby gene therapy study offers hope for fatal muscle disease

WASHINGTON (AP) — A first attempt at gene therapy for a disease that leaves babies unable to move, swallow and, eventually, breathe has extended the tots’ lives, and some began to roll over, sit and stand on their own, researchers reported. Only 15 babies with spinal muscular atrophy ...

FDA moves to ax heart benefits claim from soy foods

WASHINGTON (AP) — U.S. regulators want to remove a health claim about the heart benefits of soy from cartons of soy milk, tofu and other foods, saying the latest scientific evidence no longer shows a clear connection. The announcement by the Food and Drug Administration marks the first time ...

Doctors: Global warming is taking a toll on people’s health

WASHINGTON (AP) — Global warming is hurting people’s health a bit more than previously thought, but there’s hope that the Earth — and populations — can heal if the planet kicks its coal habit, a group of doctors and other experts said. The poor and elderly are most threatened by ...

Panel recommends new, better shingles shot

NEW YORK (AP) — A federal panel recommended that older people already vaccinated for shingles get a new, better shot. The advisory group said the just-approved vaccine made by GlaxoSmithKline works better at preventing shingles and may last longer than the one that’s been sold in the ...